Eisai

ClinicalJuly 25, 2026

Eisai Initiates Study on Algorithms for Intracerebral Hemorrhage and Seizures in Alzheimer's Disease

Eisai Inc. is conducting a retrospective study to develop algorithms for identifying intracerebral hemorrhage and new-onset seizures in Alzheimer's patients using claims data linked to electronic health records.

ClinicalJuly 8, 2026

Eisai Initiates Post-Marketing Study of Jyseleca in Korea to Assess Safety and Efficacy

Eisai Korea Inc. is conducting a post-marketing study to evaluate the safety and efficacy of Jyseleca (Filgotinib Maleate) in Korean participants.

ClinicalJuly 4, 2026

Eisai's E6742 Shows Promise in Systemic Lupus Erythematosus Study

E6742 is being evaluated for efficacy in systemic lupus erythematosus compared to placebo, with results expected at Week 24.

Sponsor company

Mechanism of action

Recent signals(4)

Eisai Initiates Study on Algorithms for Intracerebral Hemorrhage and Seizures in Alzheimer's Disease

Eisai Initiates Post-Marketing Study of Jyseleca in Korea to Assess Safety and Efficacy

Eisai's E6742 Shows Promise in Systemic Lupus Erythematosus Study

Upcoming milestones

Related catalysts

Indications

Therapeutic areas

Get signals before the market moves

Eisai's Fycompa Injection Safety Study for Epilepsy Underway